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Engineering intracellular biomineralization and
biosensing by a magnetic protein
Yuri Matsumoto1, Ritchie Chen2,3, Polina Anikeeva2,3 & Alan Jasanoff1,4,5
Remote measurement and manipulation of biological systems can be achieved using
magnetic techniques, but a missing link is the availability of highly magnetic handles on
cellular or molecular function. Here we address this need by using high-throughput genetic
screening in yeast to select variants of the iron storage ferritin (Ft) that display enhanced iron
accumulation under physiological conditions. Expression of Ft mutants selected from a library
of 107 variants induces threefold greater cellular iron loading than mammalian heavy chain
Ft, over ﬁvefold higher contrast in magnetic resonance imaging, and robust retention on
magnetic separation columns. Mechanistic studies of mutant Ft proteins indicate that
improved magnetism arises in part from increased iron oxide nucleation efﬁciency.
Molecular-level iron loading in engineered Ft enables detection of individual particles inside
cells and facilitates creation of Ft-based intracellular magnetic devices. We demonstrate
construction of a magnetic sensor actuated by gene expression in yeast.
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M
agnetic approaches to biological experimentation are
particularly attractive because they interact minimally
with biological processes, rarely incur damage and have
already led to powerful manipulation and imaging techniques.
Existing magnetic biotechnologies are of limited value for
studying molecular and cellular level phenomena, however. The
best known magnetic measurement techniques, nuclear magnetic
resonance and magnetic resonance imaging (MRI), are ill-suited
for analysis of speciﬁc molecular phenomena in cells and tissue.
In vivo nuclear magnetic resonance spectroscopy is too insensitive
to permit robust measurements of most biomolecules1. Molecular
MRI measurements can be made using contrast agents
that combine magnetic properties with other functionalities2–5,
but these agents need to be delivered exogenously. Techniques
for magnetic modulation of biological systems have been
demonstrated at cellular level6–8, but also tend to depend on
exogenous nanoparticles that are difﬁcult to apply to biological
systems. Although manipulation of cellular magnetism and
magnetic image signals has also been demonstrated using
genetic techniques9–14, the effects tend to be weaker or less
speciﬁc than approaches based on synthetic magnetic
nanoparticles, in part because the molecular organization of
magnetic material in cells is less controlled.
A strongly magnetic protein could provide a basis for robust
modulation or detection of well-deﬁned molecular-level
phenomena. A promising starting point for generation of such
a molecule is ferritin (Ft), an iron storage protein found in most
animal, plant and bacterial cells15. Ft proteins consist of a
spherical shell of 24 identical or closely homologous polypeptide
chains, in which a reservoir of hydrated iron oxide accumulates
and can be rapidly mobilized according to physiological needs. Ft
variants have been used as magnetic gene reporters12,13,
expressible cellular imaging agents16–18 and components of
magnetically responsive genetic devices19, but Ft is much
less potent than synthetic nanoparticles of similar volume and
often contains far fewer iron atoms than its core structure could
in principle accommodate20. In vitro manipulation of Ft
mineralization has enabled the generation of highly magnetic
species21, but the resulting protein complexes cannot be applied
in conjunction with genetic techniques and suffer similar
limitations to those of synthetic nanoparticles.
To address these limitations, we designed a strategy for
enhancing the magnetic properties of intracellularly expressed Ft
in a systematic and high-throughput fashion. In this paper, we
present our approach and its success in isolating mutant Ft
variants that biomineralize iron more effectively than their
natural counterparts. We characterize the selected mutants and
show that their enhanced iron loading capability may arise from
improvements to iron oxide nucleation. Finally, we show that the
new ‘hypermagnetic’ Ft variants act as genetically encodable tools
for multiscale cellular imaging, magnetic manipulation of cells
and construction of intracellular magnetic devices capable of
sensing molecular-level phenomena.
Results
Screening for Ft variants with enhanced biomineralization.
Our biomaterial engineering approach was based on the
hypothesis that mutant Ft molecules that sequester iron
compounds most effectively would also form complexes with
optimal magnetic properties—a view motivated by the fact that
both greater Ft iron content22 and denser, unhydrated iron oxide
mineralization21 can result in higher per-particle magnetic
moments. Iron accumulation by Ft variants is expected to
reduce cytosolic iron concentration by mass action principles, so
we established a reporting system in yeast whereby expression of
Ft mutants could be evaluated for induction of a low cytosolic
iron phenotype. In Saccharomyces cerevisiae, intracellular
iron level is regulated by the iron-responsive transcriptional
activator Aft1, which under low-iron conditions translocates into
the nucleus and regulates genes involved in iron uptake23. One
of the genes upregulated by Aft1 encodes the cell surface
high-afﬁnity iron transporter, FTR124; by monitoring expression
of an FTR1–green ﬂuorescent protein (GFP) fusion reporter25, we
could therefore identify individual cells that display low cytosolic
iron concentrations (Fig. 1a). This system was intended as a tool
for selecting mutant Ft variants that robustly sequester cellular
iron, and that would therefore induce greater FTR1–GFP
expression and ﬂuorescence than Ft variants with less potent
iron binding capacity.
As a template for random mutagenesis and screening, we
choose to work with a Ft from the thermophilic bacterium
Pyrococcus furiosus (PFt). PFt has the advantage that it is highly
thermostable (Tm4120 C)26, and, therefore, likely to be more
tolerant to mutations introduced to alter biomineralization than
human heavy chain Ft (HFt; Tm¼B77 C)27, which has been
used for the majority of biotechnological applications of Ft in the
past. In addition, PFt forms homooligomeric protein shells that
require only a single polypeptide, in contrast to conventional
mammalian Fts that incorporate two chains, making PFt
structure and chemistry simpler and more predictable. To
facilitate isolation and analysis of PFt variants, we fused an
afﬁnity tag (Strep-tag II) to the N terminus of PFt to form a
construct abbreviated SPFt (Supplementary Fig. 1a). The tag had
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Figure 1 | Fluorescent reporter system used to probe intracellular iron
mineralization by Ft. (a) Schematic diagram of yeast cells containing an
iron-responsive reporting system. Sequestration of cytosolic iron (red dots)
into Ft (grey) triggers translocation of an iron-responsive transcription
factor, AFT1 (orange), into the nucleus, where it induces transcription of an
FTR1–GFP fusion protein (blue/green). Iron accumulation by effective Ft
variants therefore results in a green signal (right). (b) Yeast cells
transformed with empty vector (Vec), SPFt and the SPFt mutant E94G/
K142R, which lacks iron mineralization capability, were incubated in
minimum media overnight. Differences in FTR1–GFP expression are visible
in the ﬂuorescence micrographs at right, with SPFt but not E94G/K142R
effective at upregulating the reporter; corresponding phase contrast images
are shown at left. Scale bar, B10 mm. (c) FACS histograms showing the
distribution of GFP-associated ﬂuorescence observed in yeast cell
populations transformed with vector, SPFt and E94G/K142R.
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minimal effect on protein folding and iron loading functions of
the protein (Supplementary Figs 1b–e). SPFt was expressed
in yeast cells bearing the FTR1–GFP reporter and induced
elevated ﬂuorescence, compared with control cells bearing no
SPFt or harbouring a compromised SPFt with E94G and K142R
substitutions that eliminate ferroxidase activity of the protein
(Fig. 1b). Results of ﬂuorescence microscopy were further
validated by ﬂuorescence-activated cell sorting (FACS) analysis
(Fig. 1c). Fluorescence histograms from cells transfected with a
SPFt expression plasmid displayed a peak of notably higher
ﬂuorescence, indicating upregulation of the ﬂuorescent reporter; a
second peak with ﬂuorescence comparable to vector control
transfected cells was observed under saturating growth conditions
and probably arises from SPFt expression plasmid loss in some
cells. These results were consistent with the explanation that SPFt
expression sequesters cytosolic iron and boosts FTR1–GFP
reporter expression.
To isolate mutants that preferentially biomineralize more iron
in vivo, we subjected the entire PFt coding sequence in SPFt to
PCR-based random mutagenesis. After transfection, this resulted
in a library of 10 million yeast clones expressing randomly
mutated SPFt variants with an average mutation rate of one
nucleotide change per gene (Supplementary Fig. 2). This relatively
low mutation rate was chosen to avoid accumulation of
deleterious mutations, which could obscure beneﬁcial but rare
mutations. The yeast library was incubated in a minimum media
and sorted by FACS to obtain cells exhibiting highest levels of
FTR1–GFP ﬂuorescence. Cells in the top 5% were propagated for
a subsequent round of sorting (Fig. 2a), and the procedure was
repeated. After four rounds (Fig. 2b), we sequenced the sorted
population and identiﬁed mutations that were enriched among
the selected yeast cells (Supplementary Table 1). Following
retesting of the individual-enriched mutations, three were chosen
for further analysis: L55P, F57S and F123S.
Characterization of selected SPFt mutants. To conﬁrm the Ft
dependence of iron reporter expression in the selected clones,
plasmids for SPFt L55P, F57S and F123S were isolated and
retransformed for reanalysis by FACS; ﬂuorescence histograms
were consistent with the screening results (Fig. 2c). As an
additional test of the iron accumulation phenotype, we incubated
the three selected clones in iron-supplemented media and
measured the total cellular iron content (Fig. 2d) and iron content
of puriﬁed SPFt proteins (Fig. 2e,f). The most effective of the SPFt
mutants, L55P, induced 1.6±0.2 (mean±s.e., n¼ 3) times
greater cellular iron accumulation than wild-type SPFt and
2.6±0.3 times greater accumulation than HFt. Compared with
SPFt, the L55P mutant also exhibited almost double the number
of iron atoms per Ft 24-mer, indicating that the cellular
biomineralization phenotype originates largely from an increase
in iron sequestration by Ft at the molecular level. For both L55P
and F57S mutants, signiﬁcant enhancement of cellular iron
accumulation (Student’s t-test, P¼ 0.002, n¼ 6 for L55P and
P¼ 0.003, n¼ 6 for F57S) and molecular-level Ft iron loading
(P¼ 0.00003, n¼ 6 for L55P and P¼ 0.02, n¼ 4 for F57S) were
observed. Further gains could not readily be obtained by
combining these mutations or by performing additional random
mutagenesis on the isolated clones. The results nevertheless
prove for the ﬁrst time that intracellular Ft biomineralization
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Figure 2 | Selection of SPFt mutants by high-throughput genetic screening. (a) Summary of the ﬂuorescence-activated cell sorting (FACS)-based yeast
genetic screening procedure. Control yeast cells lacking the FTR1–GFP reporter (neg) or positive cells harbouring the reporter and a SPFt gene library (Lib)
were grown in minimum media. The yeast populations were presorted to remove debris and aggregated cells, and then used to establish a criterion (green
outline) designed to reject cells lacking a functional reporter construct. From among Lib cells that passed this criterion, roughly 5% of cells which displayed
the highest GFP ﬂuorescence intensities (black label) were selected during each FACS run. Multiple rounds of selection and regrowth were performed
(arrows) to enrich library mutants which induced the highest levels of ﬂuorescent reporter expression. (b) A histogram showing the distribution of GFP
ﬂuorescence intensity in the yeast cell population transformed with the initial library (Lib, red), and following one to four successive rounds of enrichment
(S1–S4). (c) Flow cytometry distributions of GFP ﬂuorescence intensity of yeast cells transformed with SPFt (red) and three mutants identiﬁed through the
screen, L55P (green), F57S (cyan) and F123S (magenta) incubated in minimal media overnight. Cytosolic iron content of intact yeast (d) and molecular-
level iron loading by puriﬁed SPFt variants (e) was measured for each of the selected mutants using a bathophenanthrolinedisulfonate-binding assay
following 16 h incubation of the corresponding cells in iron-rich medium. Error bars denote s.e.m. of three or more independent measurements. (f) Native
gel analysis of puriﬁed SPFt and mutant nanoparticles stained with Coomassie blue for protein content (top) and Prussian blue for iron content (bottom),
showing substantially increased iron content of the selected SPFt mutants.
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processes can be engineered to produce substantial gains in iron
accumulation by individual protein macromolecules.
The proteins were characterized to determine their stability
and magnetic properties. Because melting of SPFt variants occurs
only above boiling temperature, stability was examined by
titration with the denaturant guanidinium hydrochloride
(GdmHCl). Both wild-type SPFt and the three selected variants
showed similar GdmHCl titration proﬁles in both native and
iron-saturated states (Supplementary Fig. 3). This is consistent
with the data of Fig. 2f, showing similar protein expression levels
for each variant. Magnetization curves of the variants
(0.1mgml 1 Fe) were determined by superconducting quantum
interference device magnetometry at 5 K (Supplementary Fig. 4).
All variants showed near-linear magnetization curves with
minimal hysteresis and no evidence of saturation in the range
from  10,000 to 10,000Oe; this indicates that all the SPFt
holomers are predominantly paramagnetic under the conditions
assessed. A slight pinching in the  2,000 to 2,000Oe range was
observed for wild-type SPFt and mutant F57S, consistent with
previously reported Ft magnetization curves28 and possibly
indicative of ferrihydrite mineralization29. Approximate
magnetic moments per mole of particles at 10,000Oe were
estimated in conjunction with the iron loading measurements
from Fig. 2e, resulting in values of 90 (wild-type SPFt), 260
(L55P), 250 (F57S) and 160 (F123S) J/T.
Mechanistic analysis of biomineralization by SPFt variants. In
an attempt to understand the mechanism by which primary
sequence mutations in SPFt lead to enhanced iron accumulation
in the selected Ft holomers, we performed a series of character-
ization experiments. By inspecting the crystal structure of PFt30,
we saw that all three mutant residues point towards the inside of
the iron storage cavity and lie on the B and D helices close to a
site thought to be involved in oxidation of Fe2þ ions that enter
the PFt core (Fig. 3a). We speculated that the mutations might
therefore affect either the enzymatic functionality of PFt or the
structure of the iron oxide core itself. To test these ideas, we
began by measuring the iron assimilation and release kinetics of
the SPFt variants. No signiﬁcant differences in iron oxidation (the
initial step in core formation) or iron release rates were found
(Supplementary Table 2).
To examine potential structural effects of the mutations, we
characterized the puriﬁed protein nanoparticles by high-resolu-
tion cryo-electron microscopy (cryo-EM), a powerful technique
that allows imaging of proteins in the near-native environment.
Micrographs conﬁrmed that SPFt and the variants all form 12 nm
cage-like structures as expected (Fig. 3b). Image autocorrelation
analysis indicated the presence of electron dense centres of 4–
8 nm diameter for each variant (Supplementary Fig. 5). The L55P
variant exhibited a marginally wider autocorrelation proﬁle than
other variants, possibly indicating a larger mean core size, while
the F123S displayed the narrowest proﬁle. There was more
striking variation in the frequency of electron dense cores
discernible among the four SPFt variants, however. Only
68.3±1.3% (mean±s.e.m.) of wild-type SPFt nanoparticles
contained dark core structures, whereas 96.1±0.1%, 87.0±0.3%
and 78.3±1.5% of the L55P, F57S and F123S mutants,
respectively, appeared electron dense (Fig. 3c). Increased core
formation in each mutant was signiﬁcant with respect to SPFt
(t-test; P¼ 0.03 for L55P, P¼ 0.04 for F57S, P¼ 0.04 for F123S;
n¼ 2 samples with 400 particles per sample), suggesting that an
increased ability of the mutant proteins to nucleate mineral core
formation might largely account for their ability to accumulate a
larger number of iron atoms per protein molecule. This
explanation might also be compatible with the ﬁnding that the
selected SPFt mutations could not be combined to further
improve iron loading, given the possibility that enhanced mineral
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Figure 3 | Structural analysis of SPFt variants. (a) X-ray crystal structure of PFt displaying the internal cavity of the protein in which one of the subunits is
highlighted in yellow (left panel)30. Enlarged image of the highlighted subunit (right) shows the relative positions of sidechains mutated in the selected
biomineralization mutants (L55P, F57S and F123S) with respect to the ferrooxidase residues (yellow) and the known iron binding sites (grey balls). (b)
Cryo-EM images of puriﬁed SPFt, L55P, F57S, and F123S, showing formation of 12 nm spherically shaped nanoparticles in each case. SPFt samples also
display differences in electron dense iron core formation, as indicated by the variable frequency of ‘empty’ particles in the images (for example, yellow
arrowheads). Scale bar, 50 nm. (c) The percentage of particles containing electron dense cores was computed by analysing 400 particles in cryo-EM
images of each SPFt variant. All selected mutants displayed higher frequencies of core formation than the starting clone (t-test, Pr0.04), with L55P
showing the greatest effect. Error bars denote s.e.m. of measurements from two independent samples.
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nucleation and growth at one site might not be compatible with
nucleation directed at another site, and that competing nucleation
and growth at multiple sites decreases homogeneity of mineral
crystal formation31.
Magnetic sorting and imaging using hypermagnetic SPFt. Our
strategy for engineering hypermagnetic SPFt variants was pre-
dicated on the notion that iron sequestration by SPFt mutants
would accompany enhanced magnetic properties. To demonstrate
this, we explored the utility of hypermagnetic SPFt variants in
imaging and high-gradient magnetic cell separation (HGMS)
applications. For MRI experiments, the same yeast samples used
for the iron assays in Fig. 2d were pelleted and imaged in a 7 T
magnet using a spin-echo acquisition sequence. The transverse
relaxation rate (1/T2) of cells transformed with the most iron-rich
Ft mutant, L55P, was signiﬁcantly higher than that of cells
expressing wild-type SPFt (58.2±3.7 s 1 vs 30.0±2.5 s 1, t-test
P¼ 0.001, n¼ 4) or human HFt (21.9±0.9 s 1, P¼ 0.001,
n¼ 3), indicating that the hypermagnetic mutant L55P indeed
shows higher sensitivity as an intracellularly expressed MRI
contrast agent (Fig. 4a). The ability of SPFt L55P to enhance
magnetic capture in HGMS was assessed by comparing the
mutant protein to wild-type SPFt and Ft-free control cells. Yeast
cells-expressing L55P were retained with four times greater
efﬁcacy than cells transformed with SPFt (Fig. 4b), demonstrating
that the increased cellular magnetization due to expression of
hypermagnetic mutant protein nanoparticles signiﬁcantly
improved the sensitivity of magnetic cell sorting process (t-test;
P¼ 0.007, n¼ 3). HGMS and imaging results could not be
explained by differences in the protein expression levels of wild-
type SPFt versus the hypermagnetic mutant L55P; these variants
expressed at similar levels of 0.45±0.03% and 0.53±0.07% of
total soluble protein per cell, respectively. Moreover, the nor-
malized transverse relaxation rates (1/T2 per mM Fe) of cells
transformed with wild-type SPFt and the hypermagnetic mutants
L55P, F57S and F123S were all very similar: 17.4±2.0, 21.5±1.9,
19.2±1.3 and 19.2±2.5mM 1 s 1 for wild type, L55P, F57S
and F123S, respectively. This indicates that the observed differ-
ences in magnetic behaviour are primarily due to the variation in
the number of iron atoms accumulated in these cells, rather than
to differences in per-iron relaxivity or magnetic moment.
Because enhanced mineral accumulation and magnetism is
explicitly associated with SPFt nanoparticles, as opposed to
cellular mineral content more generically9,10,32, we hypothesized
that the mutants identiﬁed here could provide means for
engineering molecular-scale imaging markers and devices. At
an ultrastructural level, SPFt mutants could for instance
constitute effective genetically encoded labels for electron
microscopic investigations of cells18. To address this possibility,
we examined transmission electron microscopy (TEM) images of
yeast transfected with SPFt L55P or with an empty control vector.
Yeast expressing the SPFt variant showed distinct puncta of
elevated electron density, each close in size to that expected for a
Ft mineral core and visible on close examination of arbitrary
cytosolic ﬁelds of view (Fig. 5a). Comparable images from control
did not reveal similar puncta. As a quantitative indication of this
difference, we used an automated template-matching procedure
to identify approximately Gaussian electron-dense spots of 7 nm
full width at half height in multiple TEM images of both
SPFt-expressing and control yeast cells. Puncta that closely
matched the template (correlation coefﬁcient¼ 0.9) were counted
in cytosolic regions only (Fig. 5b). This analysis indicated a
concentration of 220±40 puncta mm 3 from SPFt cell
images (n¼ 10) but only 70±8 punctamm 3 from control
images (n¼ 4), a signiﬁcant difference (t-test P¼ 0.05)
supporting the identiﬁcation of these spots with SPFt
nanoparticles. This suggests that SPFt variants could indeed
function as TEM-detectable genetically encoded labels in
engineered yeast and perhaps other cells.
Construction of an intracellular sensor using SPFt L55P. In
addition to potential utility for magnetic cell sorting, cellular MRI
and electron microscopic investigations, the hypermagnetic SPFt
variants are potentially useful building blocks for incorporation
into magnetic molecular devices. As demonstration of this
idea, we constructed a SPFt-based magnetic biosensor for
galactose-induced gene expression in yeast (Fig. 6a). To design
the biosensor, we made use of the dependence of magnetic
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Figure 4 | Engineered SPFt mutants are effective hypermagnetic probes
in yeast. (a) Yeast cells transformed with empty vector (Vec), human
heavy chain Ft (HFt), SPFt, L55P, F57S and F123S were pelleted and imaged
in a 7 T MRI scanner. Relaxation rates (1/T2) were computed from the MRI
signal amplitudes. Inset, corresponding T2-weighted spin echo MRI image
of yeast cell pellets in microtiter wells (echo time¼ 24ms, repetition
time¼ 2,000ms). (b) Isolation of yeast cells transformed with vector
(blue), SPFt (red) and L55P (green) following application to a magnetic
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Figure 5 | Detection of intracellular SPFt particles in ultrastructural cell
images. (a) Representative TEM image of a yeast cell following transfection
with SPFt L55P and growth in overnight in medium containing 1mM ferric
citrate before sample preparation (left, scale bar, 500nm). A closeup of the
region identiﬁed by the dashed box at left region shows electron dense
puncta such as those indicated by arrowheads (top right, scale bar,
100 nm). Similar puncta are not apparent in a comparable region from
control cells (bottom right). (b) Automated analysis of TEM images from
SPFt-expressing (n¼ 10) or control cells (n¼4) enables quantiﬁcation of
puncta that correlate with coefﬁcient Z0.9 to a Gaussian spot with full
width at half height of 7 nm, comparable to the expected SPFt mineral core
size. The difference in the density of puncta in SPFt L55P-expressing versus
control cells is signiﬁcant with t-test P¼0.05.
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relaxation properties on the aggregation state of iron-loaded Ft
molecules33,34. Aggregation of puriﬁed SPFt L55P variant in
buffer could be induced by mixing puriﬁed protein with
streptavidin (SA) tetramers, which provide a multivalent
partner for interactions with the Strep-tag II moiety on SPFt.
Cluster formation could be observed at molecular scale by cryo-
EM (Fig. 6b), and also resulted in visible precipitation and
dynamic light scattering (DLS) changes (Supplementary Fig. 6).
SA-mediated clustering could be promoted substantially by
engineering SA for optimal folding and selective binding of
Strep-tag II versus biotin. The SA/SPFt oligomer ratio required
for half maximal clustering was 0.8 for optimized SA, but 60
for wild-type SA (Supplementary Fig. 7). In this respect,
the optimized SA variant achieved maximal aggregation close to
the conditions of 1:1 oligomer stoichiometry expected to optimize
clustering under idealized conditions35. On the other hand, the
large excess of wild-type SA required for SPFt clustering,
which for the optimized SA would likely inhibit aggregation,
probably reﬂects the inferior stability and SPFt-binding
characteristics of the non-engineered SA. Titration of SPFt
aggregation with optimized SA was measured by MRI, where a
half maximal change in 1/T2 was observed at SA/SPFt ratio of 0.4
(Fig. 6c), consistent with the results from DLS.
Although Ft aggregation-based sensors have been demon-
strated previously in cell-free solutions33,34, none has yet been
reported to produce detectable responses on genetically directed
intracellular expression. To demonstrate that this key step could
be achieved using the magnetic molecular sensor formed by
hypermagnetic SPFt and SA tetramers, a construct directing
constitutive expression of the SPFt mutant was cotransformed
with a galactose-inducible construct encoding optimized SA into
yeast and grown in iron-supplemented medium overnight. Cells
were transfered to galactose-containing medium to induce SA
expression, followed with characterization by MRI, iron
quantiﬁcation and western blot analysis at time points 0, 2 and
4.5 h after the induction of SA overexpression (Fig. 6d).
Relaxation rates were normalized by cellular iron concentration
to factor out differences in iron accumulation over time, and
results were compared with control experiments using PFt L55P,
which lacks the ability to cluster with SA, in place of SPFt L55P.
The SPFt variant displayed 7, 14 and 20% greater normalized 1/T2
than the PFt control at the 0, 2 and 4.5 h time points, respectively;
differences at 2 and 4.5 h were signiﬁcant with Student’s t-test
P¼ 0.02 and 0.04, respectively. These results are consistent with
the data showing increased relaxivity of SA-SPFt clusters versus
unclustered SPFt in buffer. In contrast, no signiﬁcant effects could
be observed when SA expression was induced in the presence of
SPFt K142R or PFt K142R mutants lacking iron-loading
functionality (Supplementary Fig. 8), indicating that iron
loading by the SPFt variants is required for relaxivity changes
measured by MRI. These results together show that genetically
encoded magnetic devices formed from SPFt mutants can be
formed and applied inside cells. Such devices represent
prototypes for a wide variety of noninvasive imaging sensors
that could be expressed in cells, where they are likely to exhibit
faster and more versatile responses than could be obtained by
altering Ft expression itself13. Yeast bearing SPFt-based magnetic
devices might also be applicable as whole-cell-based sensors in
opaque media or living organisms.
Discussion
In this report, we have shown that a high-throughput protein
selection strategy can be applied to enhance intracellular
molecular-level biomineralization within Ft variants, resulting
in proteins with the ability to induce magnetic phenotypes,
inﬂuence imaging signals at multiple scales and serve as building
blocks for intracellular magnetic devices. Mechanistic analysis of
the SPFt mutants identiﬁed here indicated that single amino acid
substitutions signiﬁcantly enhanced the uniformity of mineral
formation within SPFt expressed in yeast. This result could not
have been predicted from the PFt structure alone, validating the
random library construction approach we took, and also shows
that screening for iron sequestration phenotypes can complement
traditional site-directed mutagenesis studies36–38 to expand
knowledge about the mechanisms of iron mineralization by Ft.
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Figure 6 | Construction of a SPFt-based intracellular magnetic biosensor.
(a) Design of a genetically encoded magnetic biosensor for dynamic gene
reporting using engineered SPFt. The sensor consists of two components:
constitutively expressed SPFt L55P nanoparticles (grey) and streptavidin
(SA) tetramers (orange) expressed from a galactose-inducible gene shown
in the nucleus. When SA is upregulated, it crosslinks SPFt oligomers via
their Strep-tag II moieties (blue), forming clusters that enhance T2
relaxation rates and provide a means for magnetic detection of galactose-
induced SA expression. (b) Representative cryo-EM images showing
aggregate formation by puriﬁed SPFt L55P in the presence (below) but not
the absence (above) of SA. Scale bar, 50 nm. (c) SA-dependent changes in
the relaxation rate (1/T2) displayed by solutions of 0.2 mM SPFt L55P
holomers loaded with 520mM Fe in the presence of increasing tetramer
concentrations of an SA variant optimized for stability and Strep-tag II
binding. Error bars show s.e.m. of three independent titrations, and the inset
displays representative T2-weighted MRI images corresponding to
conditions shown in the graph. (d) Magnetic detection of SA-mediated
intracellular clustering of SPFt. SPFt L55P and galactose-inducible SA were
coexpressed in yeast as schematized in a. After 16 h in galactose-free
medium (10mM Fe), cells were transferred to 2% rafﬁnose media without
iron for 2 h. Then galactose was added to the culture at a ﬁnal concentration
of 2% to induce SA expression and cells were harvested at 0, 2 or 4.5 h for
analysis. T2 relaxation rates measured by MRI were normalized by cell
pellet iron content and were compared with control experiments performed
with PFt L55P (grey bars), which accumulates iron but is not crosslinked by
SA. Normalized 1/T2 values at 2 h and 4.5 h were signiﬁcantly higher in the
SPFt-expressing cells (Student’s t-test P¼0.02–0.04, n¼ 3), consistent
with the mechanism in a and the results of c. Error bars indicate s.e.m. of
three independent experiments and corresponding protein levels revealed
by Western blotting against SA and the Strep-tag II moiety of SPFt are
presented above.
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The speciﬁc mutagenesis and screening approach taken here is
one of a universe of approaches that could have been taken to
obtain desirable Ft biomineralization mutants. Selecting for iron
accumulation as opposed to magnetic properties biased the screen
towards variants with increased mineral core formation (Fig. 3 and
Supplementary Fig. 5), potentially enhancing the performance of
selected variants as TEM labels (Fig. 5). For magnetic applications
such as imaging and magnetic sorting (Fig. 4), as well as magnetic
biosensing (Fig. 6), screening directly for magnetic properties
might have been more direct, but magnetic assays tend to be both
less sensitive and cruder. For instance, our own initial experience
with magnetic column-based selection approaches (cf. Fig. 4b)
revealed several sources of artifacts, ranging from nonspeciﬁc
column adhesion to cell clumping, which would compromise the
efﬁcacy of a screen. Although further improvement in magnetic
screening techniques is certainly possible in the future, indirect
screening using optical approaches proved useful here, as in our
earlier work with magnetically active MRI sensors39. With either
type of approach, careful molecular analysis of selected clones must
be performed to avoid mutations unlinked to the desired
phenotype (such as changes in clonal growth rate), but
nevertheless artiﬁcially favored by the screening technique.
Although all of our experiments were performed in yeast, the
protein engineering principles applied here and potentially the
speciﬁc clones identiﬁed could be applied for biotechnological
applications in other eukaryotic or prokaryotic cellular environ-
ments. Further optimization could be necessary to enhance Ft
variant expression in the desired host, or to adapt the magnetic
proteins to iron homoeostasis and protein folding conditions in
other systems. In any context, manipulating mineral nucleation
could prove to be a general and versatile route for tuning
intracellular biomineralization, particularly if unnatural mineral
species are desired40. Protein engineering approaches like those
introduced here could also be used to engineer additional
metalloproteins, and could further alter other parameters of
genetically expressed magnetic biomaterials and biosensors.
Methods
Yeast strain and handling methods. We used the haploid yeast (S. cerevisiae)
strain BY4742/FTR1–GFP (MAT a FTR1–GFP::HISMX his3D1 leu2D0 lys2D0
ura3D0)25 (gift from Dr Christopher Burd) as a host for expression of all Ft
variants. We grew yeast cells in a dropout medium without histidine (SD-HIS)
made with a dry culture medium (Teknova, Hollister, CA) or in a YPAD medium:
10 g l 1 yeast extract (BD Biosciences, San Jose, CA), 20 g l 1 of Bacto Peptone
(BD Biosciences), 20mg l 1 of adenine hemisulfate and 20 g l 1 glucose. We
transformed yeast cells with expression plasmids using the Frozen-EZ Yeast
Transformation II kit (Zymo Research, Irvine, CA).
Construction of Strep-tag II/ferritin fusion proteins. We used Escherichia coli
NEB10b cells (New England Biolabs, Ipswich, MA) for plasmid construction. To
create an expression plasmid with a dominant selectable marker, we used the PCR
to amplify a geneticin resistant cassette, KanMX4 from a plasmid pFA6-kanMX441
kindly provided by Dr Peter Philippsen. We subcloned the PCR product containing
KanMX4 fragment into the pHVX2 yeast expression plasmid generously supplied
by Dr Hennie Van Vuuren42. We then made a point deletion to destroy a
superﬂuous EcoRI site by the QuikChange Lightning Kit (Agilent Technologies,
Santa Clara, CA) to yield the host plasmid, pHVX2G, used for subsequent
expression of Ft constructs in our experiments. We ampliﬁed ferritin gene of PFt
from the genomic DNA of the bacteria (ATCC, Manassas, VA). A Strep-tag II
sequence (WSHPQFEK), spacer (GTSS) and restriction sites were genetically fused
at the 50-end of the PFt gene and the PCR product was subcloned into pHVX2G to
yield plasmid pHVX2G-SPFt (Supplementary Table 3).
SPFt expression and afﬁnity puriﬁcation. For expression of SPFt, we inoculated
yeast cells with expression plasmids in 1ml of YPAD media with 200 mgml 1
Geneticin and incubated overnight at 30 C. We then diluted the cultures into fresh
media at OD600B0.04 and incubated them for 16 h at 30 C before harvesting. We
washed the freshly harvested yeast with 30ml of PBSþ 10mM EDTA twice and
ﬁnally resuspended in PBS. We lysed yeast cell pellet with Y-PER Plus (Thermo
Scientiﬁc, Waltham, MA), benzonase nuclease (EMD Millipore, Billerica, MA) and
protease inhibitors according to the manufacturer’s instructions. We then
centrifuged the lysate at 3,000 g for 20min at 4 C. SPFt protein was puriﬁed by
applying the cleared lysate into the Strep-Tactin sepharose column (IBA,
Goettingen, Germany) according to the manufacturer’s instructions, except EDTA
that was omitted from the wash and the elution buffers. We buffer exchanged and
concentrated the puriﬁed protein into the wash buffer using a spin ﬁlter with
100 kDa cutoff membrane (EMD Millipore). We measured the protein con-
centrations by the Pierce 660 nm Protein Assay (Thermo Scientiﬁc), with bovine
serum albumin (BSA) as a standard.
TEM of puriﬁed SPFt. For conventional TEM, we applied 1–3 ml of 0.05mgml 1
SPFt sample onto a carbon/copper-coated grid (Electron Microscopy Sciences,
Hatﬁeld, PA), removed the excess solution with a ﬁlter paper and let it dry for 30 s.
We then applied 15 ml of 1% phosphotungstic acid (pH 7.0) over the sample for
about 10 s and removed the excess stain with a ﬁlter paper. The grid was dried at
room temperature for at least 1 h before imaging with a JEOL 2010 HRTEM
instrument (JEOL, Tokyo, Japan).
For cryo-EM, we applied 5ml of the protein and buffer solution on a lacey copper
grid coated with a continuous carbon ﬁlm and removed excess sample without
damaging the carbon layer using a Gatan Cryo Plunge III (Gatan, Pleasanton, PA).
We mounted the grid on a Gatan 626 cryo-holder equipped in the TEM column and
kept it under liquid nitrogen throughout the transfer into the microscope and the
subsequent imaging session. We imaged the SPFt samples on a JEOL 2100 FEG
microscope (JEOL) using a minimum-dose method that was essential to avoid
sample damage under the electron beam. We imaged at 200 kV with a magniﬁcation
setting of 60,000 for assessing particle size and distribution and recorded the
images on a Gatan 2k 2k UltraScan CCD camera (Gatan, Pleasanton, PA).
To calculate the percentage of ﬁlled cores, we counted 400 particles per sample
and divided the number of ﬁlled particles by 400. For each SPFt variant, we
obtained cryo-EM images of the protein samples from two different batches to
calculate mean, s.e.m., and statistical parameters. To estimate core sizes,
autocorrelation functions were computed from the same TEM images (three per
variant) in Matlab, generating autocorrelation plots and radial proﬁles presented in
Supplementary Fig. 5.
Library construction. We carried out library construction using an error-prone
PCR approach43. The entire SPFt gene except for the Strep-tag II sequence was
subjected to mutagenesis over 30 error-prone ampliﬁcation cycles, which yielded on
average one amino acid mutation per SPFt gene. The linearized vector was prepared
by digesting pHVX2G with ApaI and XhoI followed by gel puriﬁcation. We
transformed yeast with the SPFt library according to the method developed by
Benatuil et al. with a few modiﬁcations. We mixed 1.5mg of digested plasmid and
0.5mg of error-prone PCR product with 100ml of electrocompetent cells (B1.6 109
cells per ml) in a disposable electroporation cuvette with 0.2 cm gap (Bio-Rad,
Hercules, CA) on ice for 5min. We electroporated the cells at 3 kV using
MicroPulser electroporator (Bio-Rad), resulting in time constants ranging from 4.8
to 5.3ms. After electroporation, we immediately transferred the cells to 1:1 mix of
1M sorbitol:YPAD medium and incubated in 30 C for 3 h. We then harvested cells
by centrifugation and resuspended in SD-HIS with 200mgml 1 of Geneticin and
incubated for 2 days before freezing them for long-term storage at  80 C. Typical
transformation efﬁciency was 0.5–1.0 107 transformants per mg of plasmid DNA.
The library diversity was tested by sequencing randomly picked 24 colonies.
Measurements of iron content in cells and puriﬁed protein. We used a col-
orimetric assay based on the protocol of Tamarit et al.44 to quantify the iron
content of yeast cells and the puriﬁed protein. This method relies on the Fe2þ -
dependent optical absorbance of bathophenanthrolinedisulfonic acid (BPS) at
535 nm at pH 5.4. As standards, we dissolved known amounts of ferrous
ammonium sulfate in 3% nitric acid.
For measuring the iron content of yeast cells, we digested 4.2 108 cells by
boiling in 200 ml of 3% nitric acid for 2 h, and centrifuged at 10,000 g for 5min. To
measure the concentration of iron in SPFt, a 1:1 ratio of puriﬁed protein and 3%
nitric acid solution were mixed and boiled for 15min followed by centrifugation at
10,000 g for 5min. In both cases, the iron quantiﬁcation assay was applied to the
supernatant of the resulting samples. Iron loading stoichiometries of the protein
samples were computed by dividing the iron concentrations by the protein
concentrations, as measured by the 660 nm Protein Assay (Thermo Scientiﬁc).
High-throughput screening. We inoculated 1 108 cells in a 20ml SD-HIS
medium containing 200 mgml 1 of Geneticin at 30 C overnight (about 16–20 h).
We harvested the cells in a culture tube and resuspended in a sterile PBS such that
the cell density was about 5 107 cells per ml. We ﬁltered the cells with a sterile
membrane with 40 mm pores immediately before sorting. Similarly, we prepared
negative control samples using the BY4742 background strain without the
FTR1–GFP reporter. We set up a ﬂow cytometry protocol using the control yeast
samples. First, the yeast population was gated with forward and side scattering
channels to remove debris and aggregated cells. We then collected cells displaying
green ﬂuorescence in the top B5%, indicating high FTR1-GFP expression.
We propagated these cells overnight in 4ml of SD-HIS medium supplemented with
200 mgml 1 of Geneticin.
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Measurement of iron oxidation and release kinetics. We monitored the kinetics
of iron oxidation by SPFt variants by an optical assay45. We prepared SPFt samples
with 100 Fe/24-mer in 100mM MOPS, pH 7.0. We added ferrous ammonium
sulfate solution (1mM), made in degassed distilled water to the protein solution
(ﬁnal concentration of 0.1 mM) at a 500-fold molar excess of iron(II). Following a
mixing dead time (B5 s), we recorded the optical absorbance of the mixture at
315 nm every 2 s for 5min. We used a disposable cuvette with a 1 cm path length
and recorded the spectra with SpectraMax M2 Microplate reader (Molecular
Devices, Sunnyvale, CA). We calculated the speciﬁc activity, deﬁned as the
micromoles of iron(III) formed per minute per milligram of 24-mer SPFt by
dividing the change in absorbance of the reaction mixture over the ﬁrst 30 s by the
extinction coefﬁcients of SPFt variants and the amount of protein in the reaction.
Extinction coefﬁcients for wild type SPFt, L55P, F57S and F123S were 2.6±0.1,
2.6±0.1, 2.7±0.1 and 2.8±0.1mMcm 1, respectively.
We measured the kinetics of iron release from preloaded SPFt variants by
monitoring time dependent formation of the BPS complex with Fe2þ released
from iron-loaded Ft variants. We used puriﬁed SPFt samples that were loaded
aerobically with 1,000 Fe atoms per molecule. These samples were diluted to a ﬁnal
concentration of 0.1 mM SPFt oligomers in an iron mobilization assay buffer that
included MOPS (0.1M, pH 7.0), sodium acetate (20mM) and BPS (1mM). We
measured the absorbance values at 535 nm every 30 s for 3 h using SpectraMax
M2 Microplate reader. We took the ﬁrst 3.5min of the data and computed the
initial rate of iron release using the standard curve constructed using freshly made
ferrous ammonium sulfate solutions.
Measurement of magnetization curves. 100 ml of each SPFt variant dispersed in
Tris buffer (0.1mgml 1 Fe) was sealed in a propylene straw using a hot press.
Zero ﬁeld cooled curves at 5 K were measured using a superconducting quantum
interference device (MPMS/XL, Quantum Design, San Diego, CA). Diamagnetic
background signal was subtracted by measuring a buffer only sample sealed in the
same manner.
Measurement of denaturation proﬁles. SYPRO dye (Life Technologies) was
diluted 25-fold from the manufacturer’s 5,000 stock into 0.1M Tris, 0.15M
NaCl, pH 8.5. 1.5 ml of each SPFt variant (0.39mgml 1) was mixed with 1.5 ml
SYPRO solution and 27ml GdmHCl to a ﬁnal concentration of 0–8M GdmHCl.
After 10min incubation at room temperature, ﬂuorescence intensity was measured
using a plate reader with excitation at 567 nm and emission at 580 nm.
Yeast cell pellet MRI. We prepared the yeast samples as described in SPFt
expression and puriﬁcation section. After we washed the cells twice with PBS sup-
plemented with 10mM EDTA, the supernatant was decanted and 100ml of the cell
suspension was loaded into the wells of a microtiter plate. Unused wells were ﬁlled
with PBS. We centrifuged the plate at 1,500 g for 3min and placed it in a 12 cm outer
diameter birdcage transceiver for imaging in a 20-cm bore Bruker 7T Avance III MRI
scanner. We imaged a 2mm slice through the cell pellet samples with the ﬁeld of view
of 5 5 cm and the data matrices were 256 256 points. We used T2-weighted spin
echo pulse sequence with multiecho acquisition; repetition time was 2 s, and echo
time ranged from 5 to 150ms in 5ms intervals. We used custom routines written in
Matlab (Mathworks, Natick, MA) to reconstruct the images and computed relaxation
time constants by ﬁtting image intensity data to exponential decay curves.
Magnetic cell sorting. High gradient magnetic separations of yeast cells were
performed using magnetic columns (Miltenyi Biotec, Bergisch Gladbach,
Germany) inserted into a Frantz Canister Separator, Model L-1CN (S. G. Frantz
Company, Inc., Tullytown, PA). Brieﬂy, we suspended yeast cells at the density of
2 108 cells per ml in a sorting buffer consisting of PBS supplemented with 2mM
EDTA and 0.5% BSA. After equilibrating the column with the sorting buffer, we
applied the yeast cells on the column in the presence of an externally applied
magnetic ﬁeld of 0.6 T followed by a wash with the sorting buffer. We then swit-
ched off the magnetic ﬁeld and eluted the cells from the column with the sorting
buffer. We collected the ﬂow through, the wash and the elution fractions from the
column into a 96-well microtiter plate. We carried out optical density measure-
ments at 600 nm to estimate the cell densities of each fraction and computed the
percentages of cells retained on the columns.
Electron microscopy analysis of SPFt particles in cells. For electron micro-
scopy, yeast cells were grown in YPD medium supplemented with 1mM ferric
citrate overnight. Cells were then harvested, washed in PBS and spheroplasted
before transferred to a ﬁx buffer (3% glutaraldehyde, 0.1 sodium cacodylate, 5mM
CaCl2, 5mM MgCl2, 2.5% sucrose). Cells were embedded in 2% ultralow melting
temperature agarose and cut into small pieces. Sample blocks were post-ﬁxed in 1%
osmium/0.1% potassium ferrocyanide in 0.1M cacodylate and 5mM CaCl2 for
30min at room temperature. Sample blocks were washed thoroughly and trans-
ferred to 1% thiocabohydrazide at room temperature for 5min followed by another
wash. The sample blocks were transferred to 1% osminum/1% potassium ferro-
cynanide in cacodylate buffer for 5min at room temperature followed by another
wash. The sample blocks were then dehydrated in increasingly concentrated
ethanol solutions and embedded in Spurr resin. Blocks were sectioned on a Leica
Ultracut UCT (Leica Microsystems Inc., Buffalo Grove, IL), stained with 2% uranyl
acetate and imaged using FEI Tecnai Spirit transmission electron microscope at
80 kV (FEI, Hillsboro, OR).
To quantify putative Ft particles, images were ﬁrst manually segmented to deﬁne
cytosolic compartments, in particular by excluding membrane, extracellular space
and vacuoles. A template for matching to the images was deﬁned by specifying a
dark Gaussian spot of 7 nm full width at half height on a white background of
20 20nm. This template was then compared with the images using Fourier-based
correlation, to identify image locations that displayed correlation coefﬁcients of 0.9
or greater when matched to the template. Groups of one or more contiguous pixels
were counted as a single particle. A total of 10 images of SPFt L55P-transfected cells
and 4 images of control cells were analysed in this way and results were scaled to
denote the concentration of qualifying puncta per cubic micron. This analysis was
performed using custom code implemented in Matlab.
Construction of T7-tagged mutant streptavidin plasmids. We used the PCR
with High-Fidelity Phusion master mix (New England Biolabs) to construct the
gene of an SA variant optimized for efﬁcient folding and selective binding of
Strep-tag II (Supplementary Table 4). The optimized SA mutant contains
N-terminal T7 tag and four mutations (E44V, S45T, V47R and W120A). We used a
plasmid, pSA1 T7SA W120A (a gift from Dr Blake Peterson)46 as a template for an
inverse PCR to introduce the following three mutations (E44V, S45T and V47R) to
obtain a new plasmid, pSA1 STm. We ampliﬁed the gene encoding mutant SA
from pSA1 STm and subcloned it into NdeI/EcoRI sites of an E. coli expression
plasmid, pT7-7 (a gift from Dr Nicholas Reiter), resulting in the pT7-7 STm vector.
A yeast expression plasmid encoding the new mutant SA was constructed with
Zeocin as a selection marker, suitable for coexpression with SPFt in yeast. We
ampliﬁed the 1.2 kb fragment containing the Zeocin resistance cassette from
pPICZA (Life Technologies, Carlsbad, CA), digested with BstBI and AatII, and
cloned into pSA1 T7SA to replace TRP1 marker, thereby producing the pSAZ
T7SA plasmid. The gene encoding optimized SA was ampliﬁed from pSA1 STm,
digested with NheI and XhoI and cloned into pSAZ T7SA to replace T7SA with the
mutant SA gene and yield the pSAZSTm plasmid.
Bacterial expression and puriﬁcation of SA variants. To express SA variants, we
transformed E. coli with the plasmid, pT7-7 STm and grown in M9 minimum
medium supplemented with 100mgml 1 ampicillin at 37 C. Once the culture
reached OD600B0.8, we induced the recombinant protein expression with 0.4mM
isopropyl b-D-1-thiogalactopyranoside (IPTG) for 4 h at 30 C. We harvested and
lysed cells with BugBuster reagent (EMD Millipore) supplemented with protease
inhibitor cocktail III (EMD Millipore) and Lysonase Bioprocessing Reagent (EMD
Millipore) for 30min at room temperature. Insoluble fractions were removed by
centrifugation at 10,000 g for 40min. The soluble fraction of lysate was used for the
afﬁnity puriﬁcation of optimized SA using T7-Tag Afﬁnity Puriﬁcation Kit (EMD
Millipore) according to the manufacturer’s instructions. We then buffer exchanged
the puriﬁed protein and concentrated into the assay buffer. Wild-type SA was
purchased from Sigma-Aldrich (St Louis, MO). Protein concentrations were deter-
mined using the 660 nm Protein Assay (Thermo Scientiﬁc) with BSA as a standard.
DLS measurements. We performed DLS measurements on a DynaPro DLS
system (Wyatt Technology, Santa Barbara, CA), at 30 C with averaging over 72
acquisitions each and a 2 s integration time. The laser power was set to 25%. We
mixed 16 ml of 0.2 mM 24-mer SPFt sample with various concentrations of SA
tetramers, brieﬂy vortexed, and incubated for 5min before making the DLS
measurements in triplicates.
Coexpression of SPFt variants and SA in yeast. To test the SPFt-based
biosensing system in cells, we transformed yeast with two expression plasmids,
pHVX2G-SPFt-L55P and pSAZSTm encoding SPFt L55P or optimized mutant SA,
respectively. Control experiments were performed using plasmids encoding PFt
L55P, SPFt E94G/K142R, or PFt E94G/K142R in place of SPFt L55P. We ﬁrst
incubated the yeast cells in a rich medium with 2% glucose and 10mM ferric citrate
overnight to allow SPFt or PFt expression and iron loading. We then transferred
the yeast cells into 2% rafﬁnose plus 0.1% glucose medium and incubated for 2 h.
We then induced expression of SA by adding galactose at a ﬁnal concentration of
2% and harvested cells at 0, 2 and 4.5 h time points to measure expression levels
and make MRI and iron content measurements from cell pellets.
Western blot analysis of yeast cell pellets. For western blotting experiments, the
whole cell lysate samples were prepared from yeast cells freshly harvested after
overnight incubation according to the method developed by von der Haar with a few
modiﬁcations47. Equivalent numbers of yeast cells (2.1 108) were resuspended in
100ml of the lysis buffer and boiled for 10min. The cell suspensions were neutralized
by the addition of 2.5ml of 4M acetic acid, vortexed for a minute, and boiled for
another 10min. We then added 25ml of the loading buffer to the samples and
centrifuged them at 10,000 g for 5min before loading onto a 12% Mini-Protein TGX
Precast gel (Bio-Rad). We ran the protein gels at 160V for 30min and transferred
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the separated proteins onto PVDF membranes (Bio-Rad) at 100V for 40min at 4 C.
The membranes were blocked with 5% fat-free milk in Tris-buffered saline
(AMRESCO, Solon, OH) containing 0.1% Tween 20 (TBST) for 30min at 4 C. For
visualization of SPFt variants, we washed the membranes once with TBST for 5min
and incubate them with Strep-Tactin-horseradish peroxidase conjugate (IBA,
Goettingen, Germany) at 1:4,000 dilution in TBST for 1 h at room temperature. For
imaging expression of SA, we used an anti-streptavidin antibody conjugated to
horseradish peroxidase (Abcam, Cambridge, UK) at 1:10,000 dilution in TBST. After
washing the membranes three times with TBST, we visualized the SPFt and SA
bands with a chromogenic substrate Opti 4CN (Bio-Rad) according to the
manufacturer’s instructions. Images of the membranes were taken and processed
with ImageJ software for quantitative analysis.
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